# Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule

> **NCT04094558** · NA · COMPLETED · sponsor: **University of Calgary** · enrollment: 30 (actual)

## Conditions studied

- Proof of Concept
- Irritable Bowel Syndrome

## Interventions

- **DEVICE:** Ingestible capsule
- **PROCEDURE:** Sedated EGD
- **DIAGNOSTIC_TEST:** Lactulose Breath Test

## Key facts

- **NCT ID:** NCT04094558
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-27
- **Primary completion:** 2022-06-16
- **Final completion:** 2022-06-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094558, "Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04094558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*